πŸ‡ΊπŸ‡Έ FDA
Patent

US 12070506

Steroids and antibody-conjugates thereof

granted A61KA61K31/58A61K31/685

Quick answer

US patent 12070506 (Steroids and antibody-conjugates thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Aug 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/58, A61K31/685, A61K31/7048, A61K47/542